NO992502L - 2-Imidazolinylaminoindazolforbindelser nyttige som <alfa>-2 adrenerge reseptoragonister - Google Patents
2-Imidazolinylaminoindazolforbindelser nyttige som <alfa>-2 adrenerge reseptoragonisterInfo
- Publication number
- NO992502L NO992502L NO992502A NO992502A NO992502L NO 992502 L NO992502 L NO 992502L NO 992502 A NO992502 A NO 992502A NO 992502 A NO992502 A NO 992502A NO 992502 L NO992502 L NO 992502L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen
- unsubstituted
- compounds
- imidazolinylaminoindazole
- alfa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Resins (AREA)
Abstract
Denne oppfinnelse vedrører forbindelser som har struktur (I) hvor: a) RT er hydrogen; eller alkyl; b) R2 er hydrogen; alkyl eller null; c) R3 er valgt fra hydrogen; usub- stituert C^ alkanyl; amino, hydroksy, merkapto; C^-C, alkyltio eller alkoksy; Ci-C3 alkylamino eller C^-C3 dialkyl- amino; cyano; og halo; d) R,, Rs og R, er hver uavhengig valgt fra hydrogen; usubstituert C^-C^ alkanyl, alkenyl eller alkynyl; cykloalkanyl, cykloalkenyl; usubstituert C^- C3 alkyltio eller alkoksy; hydroksy; tio; nitro; cyano; amino; C^-Cj alkylamino eller C^-C., dialkylamino og halo; e) når R2 er null, er binding (a) en dobbeIbinding; f) for- bindelsen er ikke 7-brom-6-(2-imidazolinylamino)indazol; og enantiomerer, optiske isomerer, stereoisomerer, diastereo- merer, tautomerer, addisjonssalter, biohydrolyserbare amider og estere, og farmasøytiske sammensetninger inne- holdende slike nye forbindelser, og anvendelsen av slike forbindelser for å forhindre eller behandle forstyrrelser modulert av alfa-2-adrenerge reseptorer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3174096P | 1996-11-25 | 1996-11-25 | |
PCT/US1997/020551 WO1998023609A1 (en) | 1996-11-25 | 1997-11-21 | 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992502D0 NO992502D0 (no) | 1999-05-25 |
NO992502L true NO992502L (no) | 1999-07-26 |
Family
ID=21861136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992502A NO992502L (no) | 1996-11-25 | 1999-05-25 | 2-Imidazolinylaminoindazolforbindelser nyttige som <alfa>-2 adrenerge reseptoragonister |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0944620A1 (no) |
JP (1) | JP2001506599A (no) |
KR (1) | KR20000069104A (no) |
CN (1) | CN1244864A (no) |
AR (1) | AR010643A1 (no) |
AU (1) | AU5433998A (no) |
BR (1) | BR9713535A (no) |
CA (1) | CA2272644A1 (no) |
CO (1) | CO4910166A1 (no) |
CZ (1) | CZ183999A3 (no) |
HU (1) | HUP9904660A3 (no) |
ID (1) | ID22676A (no) |
IL (1) | IL130067A0 (no) |
NO (1) | NO992502L (no) |
NZ (1) | NZ335882A (no) |
PE (1) | PE47099A1 (no) |
SK (1) | SK69699A3 (no) |
TR (1) | TR199901542T2 (no) |
WO (1) | WO1998023609A1 (no) |
ZA (1) | ZA9710576B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
US6433186B1 (en) | 2000-08-16 | 2002-08-13 | Astrazeneca Ab | Amidino derivatives and their use as thormbin inhibitors |
US20100311965A1 (en) | 2007-12-28 | 2010-12-09 | Carna Biosciences Inc. | 2-aminoquinazoline derivative |
WO2010074753A1 (en) | 2008-12-23 | 2010-07-01 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
CN112538074A (zh) * | 2020-12-24 | 2021-03-23 | 艾希尔(深圳)药物研发有限公司 | 一种溴莫尼定脱溴杂质的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH641782A5 (en) * | 1978-12-07 | 1984-03-15 | Siegfried Ag | 1H- and 2H-indazole derivatives |
US4526898A (en) * | 1980-09-05 | 1985-07-02 | Siegfried Aktiengesselschaft | Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole |
PT735877E (pt) * | 1993-12-17 | 2000-12-29 | Procter & Gamble | Compostos de 6-(2-imidazolinilamino)quinoxalina uteis como agonistas do receptor alfa-2 adrenergico |
US5478858A (en) * | 1993-12-17 | 1995-12-26 | The Procter & Gamble Company | 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists |
-
1997
- 1997-11-21 CN CN97181453A patent/CN1244864A/zh active Pending
- 1997-11-21 WO PCT/US1997/020551 patent/WO1998023609A1/en not_active Application Discontinuation
- 1997-11-21 CA CA002272644A patent/CA2272644A1/en not_active Abandoned
- 1997-11-21 ID IDW990412A patent/ID22676A/id unknown
- 1997-11-21 KR KR1019997004569A patent/KR20000069104A/ko not_active Application Discontinuation
- 1997-11-21 IL IL13006797A patent/IL130067A0/xx unknown
- 1997-11-21 NZ NZ335882A patent/NZ335882A/xx unknown
- 1997-11-21 BR BR9713535A patent/BR9713535A/pt unknown
- 1997-11-21 CZ CZ991839A patent/CZ183999A3/cs unknown
- 1997-11-21 TR TR1999/01542T patent/TR199901542T2/xx unknown
- 1997-11-21 HU HU9904660A patent/HUP9904660A3/hu unknown
- 1997-11-21 AU AU54339/98A patent/AU5433998A/en not_active Abandoned
- 1997-11-21 EP EP97948238A patent/EP0944620A1/en not_active Withdrawn
- 1997-11-21 JP JP52468698A patent/JP2001506599A/ja active Pending
- 1997-11-24 CO CO97068615A patent/CO4910166A1/es unknown
- 1997-11-25 AR ARP970105524A patent/AR010643A1/es unknown
- 1997-11-25 ZA ZA9710576A patent/ZA9710576B/xx unknown
- 1997-11-25 PE PE1997001067A patent/PE47099A1/es not_active Application Discontinuation
-
1999
- 1999-05-25 NO NO992502A patent/NO992502L/no not_active Application Discontinuation
- 1999-05-25 SK SK696-99A patent/SK69699A3/sk unknown
Also Published As
Publication number | Publication date |
---|---|
ID22676A (id) | 1999-12-09 |
SK69699A3 (en) | 2000-06-12 |
WO1998023609A1 (en) | 1998-06-04 |
KR20000069104A (ko) | 2000-11-25 |
CO4910166A1 (es) | 2000-04-24 |
HUP9904660A3 (en) | 2002-02-28 |
HUP9904660A2 (hu) | 2000-06-28 |
NO992502D0 (no) | 1999-05-25 |
NZ335882A (en) | 2000-12-22 |
AU5433998A (en) | 1998-06-22 |
EP0944620A1 (en) | 1999-09-29 |
ZA9710576B (en) | 1998-09-16 |
PE47099A1 (es) | 1999-06-12 |
IL130067A0 (en) | 2000-02-29 |
TR199901542T2 (xx) | 2000-01-21 |
AR010643A1 (es) | 2000-06-28 |
CN1244864A (zh) | 2000-02-16 |
JP2001506599A (ja) | 2001-05-22 |
CA2272644A1 (en) | 1998-06-04 |
CZ183999A3 (cs) | 1999-11-17 |
BR9713535A (pt) | 2000-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4910149A1 (es) | Compuestos de 2-imidazolinilaminoindol utiles como agonistas de alfa-2 adrenoceptores | |
AR247559A1 (es) | Composicion herbicida y un compuesto derivado de 1, 3, 5-triazinas 2, 4, 6-trisustituidas, procedimiento para prepararlo, su empleo y el metodo para combatir el crecimiento de plantas no deseadas | |
AU747521C (en) | Cycloalkene derivatives, process for producing the same, and use | |
FI942881A (fi) | 2-piperatsinoniyhdisteet ja niiden käyttö | |
TR200000670T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
TR200000673T2 (tr) | FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler. | |
ATE178065T1 (de) | Kondensierte imidazol- und triazolderivate als 5- hta rezeptoragonisten | |
FI941644A (fi) | Sieniä vastustavat triatsoliyhdisteet | |
TR199901468T2 (xx) | Alfa-2 adrenosept�r agonistleri olarak yararl� guanidinil heterosikl bile�ikleri. | |
MX2021014354A (es) | Pirrolidinonas sustituidas con pirazol como herbicidas. | |
NO992502L (no) | 2-Imidazolinylaminoindazolforbindelser nyttige som <alfa>-2 adrenerge reseptoragonister | |
IL67457A0 (en) | Herbicidal cyclohexane-1,2-dione derivatives | |
TR199901486T2 (xx) | Alfa-2 adrenosept�r agonistleri olarak yararl� 2-imidazolinilamino-benzoksazol bile�ikleri. | |
BR9915950A (pt) | Benzoilpirazol substituìdo por 3-heterociclila, processo para preparar benzoilpirazóis substituìdos por 3-heterociclila, éster de ácido benzóico, derivado de 3-(heterociclila) benzeno, composição, processos para preparar composições e para controlar vegetação indesejável, uso dos benzoilpirazóis substituìdos por 3-heterociclila | |
PT1234818E (pt) | Sais de calcio de derivados de 1,5-benzodiazepina, processo para producao dos sais e drogas que os contem | |
ZA91288B (en) | Coating compound,process for its production as well as use thereof | |
ES2152319T3 (es) | Derivado del benceno util contra isquemias. | |
PE16199A1 (es) | Compuestos de 2-imidazolinilaminobenzotiazol utiles como agonistas de alfa-2 adrenoreceptores | |
GR3033333T3 (en) | Carbamoyl carboxylic acid amides | |
CA2272098A1 (en) | Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists | |
FI962322A0 (fi) | (S,S,S)-N-(1-(2-karboksi-3-(N2-mesyylilysyyliamino)propyyli)1-syklopentyylikarbonyylityrosiinin kiteinen polymorfinen muoto | |
US3115499A (en) | 1-(2-hydroxyethyl)-3-amino-2-imidazolidine-thione | |
ES2148800T3 (es) | Derivados del acido benzoilpropionico sustituidos por fluoro. | |
AU567101B2 (en) | Imidazole and triazole pesticides | |
DK0661275T3 (da) | 1-( alfa-Cyclopropyl-alfa-(substitueret oxy)-otolyl sulfamoyl) -3-(4,6-dimethoxy-2-pyrimidinyl) urinstoffer som herbicide midler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |